Clinical Trial Update: An Observational Study Called STAR-T to Learn More About the Sequential Treatment With Regorafenib and TAS-102 in Adults With Metastatic Colorectal Cancer Under Real World Conditions

View source ↗

Summary

An observational study (STAR-T) assessed sequential treatment with regorafenib followed by TAS-102 in adults with metastatic colorectal cancer under real-world …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Lonsurf (trifluridine/tipiracil)
• Stivarga (regorafenib)

Snippet

Sponsor: Bayer | Conditions: Metastatic Colorectal Cancer (mCRC) | Status: COMPLETED